Recently, the “flow cytometry kit and monitoring method for monitoring small residual lesions of acute B-lymphocytic leukemia” independently developed by Shanghai Yuanqi Biomedical Technology Co., Ltd., a subsidiary of Ruian Gene, was officially granted a national invention patent. The product is based on a full-spectrum streaming technology platform and realizes simultaneous detection of 15 colors in one tube for the first time, providing a new “one-stop” solution for accurate recurrence warning for B-ALL patients, marking an important step in the field of MRD detection of hematological tumors.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.